Compare Aurobindo Pharma with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs J.B.CHEMICALS - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA J.B.CHEMICALS AUROBINDO PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 16.0 22.5 71.0% View Chart
P/BV x 3.3 4.2 78.1% View Chart
Dividend Yield % 0.3 0.3 114.6%  

Financials

 AUROBINDO PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
J.B.CHEMICALS
Mar-18
AUROBINDO PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs830363 228.6%   
Low Rs527255 206.7%   
Sales per share (Unadj.) Rs333.9169.1 197.4%  
Earnings per share (Unadj.) Rs40.416.6 243.1%  
Cash flow per share (Unadj.) Rs51.823.4 221.0%  
Dividends per share (Unadj.) Rs2.502.00 125.0%  
Dividend yield (eoy) %0.40.6 56.9%  
Book value per share (Unadj.) Rs237.1172.5 137.4%  
Shares outstanding (eoy) m585.9183.57 701.1%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x2.01.8 111.2%   
Avg P/E ratio x16.818.6 90.3%  
P/CF ratio (eoy) x13.113.2 99.3%  
Price / Book Value ratio x2.91.8 159.7%  
Dividend payout %6.212.0 51.4%   
Avg Mkt Cap Rs m397,56925,827 1,539.3%   
No. of employees `00017.93.8 473.4%   
Total wages/salary Rs m25,8492,511 1,029.4%   
Avg. sales/employee Rs Th10,956.93,747.4 292.4%   
Avg. wages/employee Rs Th1,447.7665.7 217.5%   
Avg. net profit/employee Rs Th1,324.3367.8 360.1%   
INCOME DATA
Net Sales Rs m195,63614,135 1,384.0%  
Other income Rs m1,553366 424.6%   
Total revenues Rs m197,18914,501 1,359.8%   
Gross profit Rs m39,5192,178 1,814.2%  
Depreciation Rs m6,680570 1,172.5%   
Interest Rs m2,62635 7,524.4%   
Profit before tax Rs m31,7671,940 1,637.9%   
Minority Interest Rs m270-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-8810-   
Tax Rs m7,269552 1,316.0%   
Profit after tax Rs m23,6451,387 1,704.5%  
Gross profit margin %20.215.4 131.1%  
Effective tax rate %22.928.5 80.3%   
Net profit margin %12.19.8 123.2%  
BALANCE SHEET DATA
Current assets Rs m153,64510,470 1,467.5%   
Current liabilities Rs m120,4292,749 4,380.8%   
Net working cap to sales %17.054.6 31.1%  
Current ratio x1.33.8 33.5%  
Inventory Days Days13555 244.9%  
Debtors Days Days6478 82.0%  
Net fixed assets Rs m103,9095,811 1,788.1%   
Share capital Rs m586167 350.6%   
"Free" reserves Rs m138,32214,248 970.8%   
Net worth Rs m138,90814,416 963.6%   
Long term debt Rs m1,8000-   
Total assets Rs m264,54417,649 1,498.9%  
Interest coverage x13.156.6 23.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.8 92.3%   
Return on assets %9.98.1 123.2%  
Return on equity %17.09.6 176.9%  
Return on capital %23.813.7 174.0%  
Exports to sales %49.60-   
Imports to sales %18.80-   
Exports (fob) Rs m97,091NA-   
Imports (cif) Rs m36,741NA-   
Fx inflow Rs m97,3166,164 1,578.8%   
Fx outflow Rs m40,5891,334 3,041.7%   
Net fx Rs m56,7274,829 1,174.6%   
CASH FLOW
From Operations Rs m16,2201,231 1,318.2%  
From Investments Rs m-28,768-208 13,824.3%  
From Financial Activity Rs m19,191-595 -3,224.2%  
Net Cashflow Rs m6,656427 1,558.5%  

Share Holding

Indian Promoters % 54.1 55.4 97.7%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 8.0 3.4 234.5%  
FIIs % 27.7 3.9 710.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.2 37.0 27.6%  
Shareholders   69,601 30,437 228.7%  
Pledged promoter(s) holding % 8.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALKEM LABORATORIES  ELDER PHARMA  

Compare AUROBINDO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Upcoming IPOs, Bajaj Finance June Quarter Numbers, and Top Buzzing Stocks Today(Pre-Open)

Extending gains to the fifth consecutive session, Indian share markets witnessed volatile trading activity throughout the day yesterday and ended higher.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Jul 7, 2020 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS